BIRENDRA BHATTARAI: Open Payments
NPI 1851592802 · MOUNT DORA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 27 payments from 12 companies in 2025. Trend: 2023 $681 · 2024 $591 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $90 |
| Novo Nordisk Inc | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Phathom Pharmaceuticals, Inc. | 1 | $68 |
| Exact Sciences Corporation | 3 | $61 |
| PFIZER INC. | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Amgen Inc. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $25 |
Products named: Ozempic, VOQUEZNA, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, FARXIGA, SHINGRIX, GEMTESA, OTEZLA.
Industry payments across FL — which companies pay providers there.
